The Role of Personalized Stenosing Tenosynovitis Brace Therapy Based on 3D Printing Technology: A Prospective Cohort Study

IF 2.1 Q2 MEDICINE, GENERAL & INTERNAL

Health Science Reports Pub Date : 2024-11-18 DOI:10.1002/hsr2.70156

Guantong Sun, Xiaodong Li, Jingjing Dai

{"title":"The Role of Personalized Stenosing Tenosynovitis Brace Therapy Based on 3D Printing Technology: A Prospective Cohort Study","authors":"Guantong Sun, Xiaodong Li, Jingjing Dai","doi":"10.1002/hsr2.70156","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <h3> Objective</h3>\n \n <p>To explore the clinical effect of personalized brace based on 3D printing technology in the treatment of stenosing tenosynovitis.</p>\n </section>\n \n <section>\n \n <h3> Methods</h3>\n \n <p>From September 2021 to June 2023, 20 patients with stenosing tenosynovitis were collected and randomly divided into the experimental group and the control group, with 10 cases in each group, and each patient signed an informed consent. The experimental group was treated with personalized brace combined with External Diclofenac Diethalamine Emulgel, and the control group was treated with External Diclofenac Diethalamine Emulgel, and the clinical efficacy and pain scores of the two groups were compared.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>After 8 weeks of treatment, the degree of pain relief, metacarpophalangeal joint mobility and proximal interphalangeal joint mobility of the experimental group were significantly higher than those of the control group. The activity pain scores of both groups were reduced, but the experimental group was significantly lower than the control group (<i>p</i> < 0.05).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>For the treatment of patients with stenosing tenosynovitis, it is recommended to use personalized stenosing tenosynovitis brace therapy based on 3D printing technology combined with External Diclofenac Diethalamine Emulgel at the first visit, which can significantly reduce finger pain and improve hand function.</p>\n </section>\n </div>","PeriodicalId":36518,"journal":{"name":"Health Science Reports","volume":"7 11","pages":""},"PeriodicalIF":2.1000,"publicationDate":"2024-11-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/hsr2.70156","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Health Science Reports","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/hsr2.70156","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}

引用次数: 0

Abstract

Objective

To explore the clinical effect of personalized brace based on 3D printing technology in the treatment of stenosing tenosynovitis.

Methods

From September 2021 to June 2023, 20 patients with stenosing tenosynovitis were collected and randomly divided into the experimental group and the control group, with 10 cases in each group, and each patient signed an informed consent. The experimental group was treated with personalized brace combined with External Diclofenac Diethalamine Emulgel, and the control group was treated with External Diclofenac Diethalamine Emulgel, and the clinical efficacy and pain scores of the two groups were compared.

Results

After 8 weeks of treatment, the degree of pain relief, metacarpophalangeal joint mobility and proximal interphalangeal joint mobility of the experimental group were significantly higher than those of the control group. The activity pain scores of both groups were reduced, but the experimental group was significantly lower than the control group (p < 0.05).

Conclusion

For the treatment of patients with stenosing tenosynovitis, it is recommended to use personalized stenosing tenosynovitis brace therapy based on 3D printing technology combined with External Diclofenac Diethalamine Emulgel at the first visit, which can significantly reduce finger pain and improve hand function.

Abstract Image

查看原文本刊更多论文

基于 3D 打印技术的个性化狭窄性腱鞘炎支架疗法的作用：前瞻性队列研究

摘要] 目的探讨基于3D打印技术的个性化支具治疗狭窄性腱鞘炎的临床效果。方法 2021年9月-2023年6月，收集20例狭窄性腱鞘炎患者，随机分为实验组和对照组，每组10例，每位患者签署知情同意书。实验组采用个性化支具联合外用双氯芬酸二乙胺乳膏治疗，对照组采用外用双氯芬酸二乙胺乳膏治疗，比较两组患者的临床疗效和疼痛评分。结果治疗 8 周后，实验组疼痛缓解程度、掌指关节活动度和近端指间关节活动度明显高于对照组。两组患者的活动疼痛评分均有所降低，但实验组明显低于对照组（P <0.05）。结论对于狭窄性腱鞘炎患者的治疗，建议在首次就诊时采用基于3D打印技术的个性化狭窄性腱鞘炎支具治疗联合外用双氯芬酸二乙胺乳膏，可明显减轻手指疼痛，改善手部功能。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Health Science Reports Medicine-Medicine (all)

CiteScore

1.80

自引率

0.00%

发文量

458

审稿时长

20 weeks